12/3/24 16:30 | 11/29/24 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 53 | 5 | D | | | | | | | | | | | | | | |
12/3/24 16:30 | 12/2/24 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -3 | 5.64 | 0 | -1 | -9 | 5 | D | | | | | | | | | | | | | | |
7/2/24 07:30 | 6/28/24 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 86 | 2.87 | 0 | 30 | 5 | 673 | D | | | | | | | | | | | | | | |
5/15/24 17:30 | 5/14/24 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | P | 476 | 6.26 | 0 | 76 | 29 | 343 | D | | | | | | | | | | | | | | |
4/3/24 17:00 | 4/1/24 | VERV | Health | Drug | Pharmaceutical Preparations | Nickerson Joan | MA | O | Chief Ad | M.d | 0 | 0.00 | 0 | 3 | 62 | 9 | D | | | | | | | | | | | | | | |
4/3/24 17:00 | 4/2/24 | VERV | Health | Drug | Pharmaceutical Preparations | Nickerson Joan | MA | O | Chief Ad | S.d | -12 | 8.24 | 0 | -2 | -15 | 9 | D | | | | | | | | | | | | | | |
12/5/23 16:30 | 12/1/23 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | P | 18,000 | 10.00 | 0 | 1,800 | 17 | 12,168 | I | | | | | | | | | | | | | | |
12/1/23 16:30 | 11/29/23 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 86 | 4 | D | | | | | | | | | | | | | | |
12/1/23 16:30 | 11/29/23 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -6 | 11.45 | 0 | -1 | -12 | 4 | D | | | | | | | | | | | | | | |
12/16/22 17:00 | 12/14/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 103 | 2.87 | 0 | 36 | 543 | 43 | D | | | | | | | | | | | | | | |
12/2/22 17:00 | 12/1/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S | -20 | 22.95 | 0 | -1 | -12 | 7 | D | | | | | | | | | | | | | | |
12/1/22 17:00 | 11/29/22 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 603 | 2 | D | | | | | | | | | | | | | | |
12/1/22 17:00 | 11/29/22 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -12 | 22.10 | 0 | -1 | -20 | 2 | D | | | | | | | | | | | | | | |
11/8/22 17:51 | 11/4/22 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | S | -1,513 | 31.14 | 0 | -49 | 0 | 10,368 | I | | | | | | | | | | | | | | |
11/8/22 17:04 | 11/4/22 | VERV | Tech | Softw | Computer Programming, Data Pr | Gv 2017 Gp, L.L.C. | CA | H | Member o | S | -3,026 | 31.14 | 0 | -97 | -1 | 10,368 | I | | | | | | | | | | | | | | |
11/4/22 17:58 | 11/2/22 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | S.m | -2,655 | 33.95 | 0 | -78 | -1 | 10,466 | I | | | | | | | | | | | | | | |
11/4/22 16:16 | 11/2/22 | VERV | Tech | Softw | Computer Programming, Data Pr | Gv 2017 Gp, L.L.C. | CA | H | Member o | S.m | -5,311 | 33.95 | 0 | -156 | -1 | 10,466 | I | | | | | | | | | | | | | | |
11/2/22 21:02 | 10/31/22 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | S.m | -3,250 | 37.95 | 0 | -86 | -1 | 10,622 | I | | | | | | | | | | | | | | |
11/2/22 16:25 | 10/31/22 | VERV | Tech | Softw | Computer Programming, Data Pr | Gv 2017 Gp, L.L.C. | CA | H | Member o | S.m | -6,501 | 37.95 | 0 | -171 | -2 | 10,622 | I | | | | | | | | | | | | | | |
11/1/22 17:00 | 10/28/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 15 | 1.48 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
11/1/22 17:00 | 10/28/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -399 | 39.90 | 0 | -10 | -60 | 7 | D | | | | | | | | | | | | | | |
10/5/22 17:00 | 10/3/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 70 | 1.39 | 0 | 50 | 8 | 640 | D | | | | | | | | | | | | | | |
10/5/22 17:00 | 10/3/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -1,683 | 33.65 | 0 | -50 | -7 | 640 | D | | | | | | | | | | | | | | |
9/27/22 17:00 | 9/23/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 89 | 1.48 | 0 | 60 | | 7 | D | | | | | | | | | | | | | | |
9/27/22 17:00 | 9/23/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -2,120 | 35.34 | 0 | -60 | -90 | 7 | D | | | | | | | | | | | | | | |
8/29/22 17:00 | 8/25/22 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | M.d | 152 | 1.59 | 0 | 96 | 56 | 267 | D | | | | | | | | | | | | | | |
8/11/22 17:00 | 8/10/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 70 | 1.39 | 0 | 50 | 8 | 640 | D | | | | | | | | | | | | | | |
8/11/22 17:00 | 8/10/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -1,495 | 29.90 | 0 | -50 | -7 | 640 | D | | | | | | | | | | | | | | |
7/22/22 17:00 | 7/20/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 28 | 1.39 | 0 | 20 | | 7 | D | | | | | | | | | | | | | | |
7/22/22 17:00 | 7/20/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -698 | 34.90 | 0 | -20 | -75 | 7 | D | | | | | | | | | | | | | | |
7/21/22 17:00 | 7/19/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 70 | 1.39 | 0 | 50 | 8 | 640 | D | | | | | | | | | | | | | | |
7/21/22 17:00 | 7/19/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -1,495 | 29.90 | 0 | -50 | -7 | 640 | D | | | | | | | | | | | | | | |
7/15/22 17:00 | 7/13/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 15 | 1.48 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
7/15/22 17:00 | 7/13/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -249 | 24.90 | 0 | -10 | -60 | 7 | D | | | | | | | | | | | | | | |
7/14/22 17:24 | 7/12/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -3,387 | 20.78 | 0 | -163 | -22 | 571 | I | | | | | | | | | | | | | | |
7/6/22 12:56 | 7/1/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -607 | 15.66 | 0 | -39 | -5 | 774 | I | | | | | | | | | | | | | | |
7/1/22 14:54 | 6/29/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S.m | -822 | 15.45 | 0 | -53 | -6 | 773 | I | | | | | | | | | | | | | | |
5/13/22 16:37 | 5/12/22 | VERV | Health | Drug | Pharmaceutical Preparations | Adelman Burt A | MA | D | | P | 122 | 12.15 | 0 | 10 | 2 | 428 | I | | | | | | | | | | | | | | |
3/22/22 07:41 | 3/18/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 200 | 2.87 | 0 | 70 | 12 | 640 | D | | | | | | | | | | | | | | |
3/17/22 07:58 | 3/15/22 | VERV | Health | Drug | Pharmaceutical Preparations | Adelman Burt A | MA | D | | P | 86 | 21.38 | 0 | 4 | 1 | 418 | I | | | | | | | | | | | | | | |
3/11/22 17:59 | 3/9/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -115 | 29.01 | 0 | -4 | 0 | 826 | I | | | | | | | | | | | | | | |
2/11/22 10:40 | 2/9/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -389 | 29.46 | 0 | -13 | -2 | 830 | I | | | | | | | | | | | | | | |
2/3/22 11:43 | 2/1/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -1,033 | 29.04 | 0 | -36 | -4 | 843 | I | | | | | | | | | | | | | | |
1/28/22 17:04 | 1/26/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S.m | -4,943 | 31.12 | 0 | -159 | -15 | 878 | I | | | | | | | | | | | | | | |
1/6/22 16:36 | 1/4/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 3 | 1.39 | 0 | 2 | 0 | 569 | D | | | | | | | | | | | | | | |
1/6/22 16:36 | 1/4/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -75 | 39.90 | 0 | -2 | 0 | 569 | D | | | | | | | | | | | | | | |
12/29/21 16:38 | 12/27/21 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.dm | 68 | 1.39 | 0 | 49 | 9 | 569 | D | | | | | | | | | | | | | | |
12/29/21 16:38 | 12/27/21 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.dm | -1,956 | 40.16 | 0 | -49 | -8 | 569 | D | | | | | | | | | | | | | | |
12/27/21 18:12 | 12/22/21 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | Chief Sc | M.d | 22 | 1.48 | 0 | 15 | | 5 | D | | | | | | | | | | | | | | |
12/27/21 18:12 | 12/22/21 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | Chief Sc | S.d | -580 | 38.70 | 0 | -15 | -75 | 5 | D | | | | | | | | | | | | | | |
12/27/21 18:08 | 12/22/21 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.dm | 158 | 1.39 | 0 | 114 | 25 | 569 | D | | | | | | | | | | | | | | |
12/27/21 18:08 | 12/22/21 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.dm | -4,481 | 39.30 | 0 | -114 | -17 | 569 | D | | | | | | | | | | | | | | |
12/6/21 08:12 | 12/2/21 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | P | 128 | 32.10 | 0 | 4 | 2 | 171 | D | | | | | | | | | | | | | | |
12/6/21 08:11 | 12/2/21 | VERV | Health | Drug | Pharmaceutical Preparations | Adelman Burt A | MA | D | | P | 147 | 31.34 | 0 | 5 | 1 | 414 | I | | | | | | | | | | | | | | |
6/23/21 16:16 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Redmile Group, LLC | CA | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 118 | 1,937 | I | | | | | | | | | | | | | | |
6/23/21 16:02 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 5,225 | 19.00 | 0 | 275 | 39 | 984 | I | | | | | | | | | | | | | | |
6/22/21 17:21 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Logos Global Management LP | CA | T | | P.d | 7,030 | 19.00 | 0 | 370 | 83 | 813 | M | | | | | | | | | | | | | | |
6/22/21 17:20 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Rock Springs Capital Management LP | MD | T | | P.d | 7,030 | 19.00 | 0 | 370 | | 153 | I | | | | | | | | | | | | | | |
6/22/21 17:17 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | | P.d | 6,650 | 19.00 | 0 | 350 | 79 | 793 | D | | | | | | | | | | | | | | |
6/22/21 17:12 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Casdin Partners Master Fund, L.P. | NY | T | | P.d | 20,900 | 19.00 | 0 | 1,100 | 83 | 2,418 | D | | | | | | | | | | | | | | |
6/21/21 18:25 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Beaudoin Margaret | MA | O | VP,Finan | P.d | 19 | 19.00 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
6/21/21 18:21 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | Chief Sc | P.d | 95 | 19.00 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
6/21/21 18:20 | 6/21/21 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | P.d | 48 | 19.00 | 0 | 3 | 0 | 569 | D | | | | | | | | | | | | | | |